153 related articles for article (PubMed ID: 16498597)
41. Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity.
Agren A; Wiman B; Schulman S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):657-60. PubMed ID: 17890953
[TBL] [Abstract][Full Text] [Related]
42. Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy.
Choi JW; Pai SH
Ann Hematol; 2002 Nov; 81(11):611-5. PubMed ID: 12454697
[TBL] [Abstract][Full Text] [Related]
43. Fibrin D-dimer, haemostatic factors and peripheral arterial disease.
Lee AJ; Fowkes FG; Lowe GD; Rumley A
Thromb Haemost; 1995 Sep; 74(3):828-32. PubMed ID: 8571305
[TBL] [Abstract][Full Text] [Related]
44. Relationship between overnight neuroendocrine activity and morning haemostasis in working men.
von Känel R; Kudielka BM; Abd-el-Razik A; Gander ML; Frey K; Fischer JE
Clin Sci (Lond); 2004 Jul; 107(1):89-95. PubMed ID: 15027894
[TBL] [Abstract][Full Text] [Related]
45. Effect of ACE inhibition on the fibrinolytic system in patients requiring coronary artery bypass grafting.
Walter T; Szabo S; Kazmaier S; Suselbeck T; Borggrefe M; Hoffmeister HM
Thorac Cardiovasc Surg; 2009 Sep; 57(6):368-71. PubMed ID: 19707983
[TBL] [Abstract][Full Text] [Related]
46. Fibrinolytic system in normotensive subjects and hypertensive patients.
Armas-Hernández MJ; Hernández-Hernández R; Armas-Padilla MC; Sosa-Canache B; Cammarata R; Pacheco B; Guerrero-Pajuelo J; Israili ZH; Valasco M
Am J Ther; 2007; 14(2):177-82. PubMed ID: 17414587
[TBL] [Abstract][Full Text] [Related]
47. PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample.
Meigs JB; Dupuis J; Liu C; O'Donnell CJ; Fox CS; Kathiresan S; Gabriel SB; Larson MG; Yang Q; Herbert AG; Wilson PW; Feng D; Tofler GH; Cupples LA
Obesity (Silver Spring); 2006 May; 14(5):753-8. PubMed ID: 16855181
[TBL] [Abstract][Full Text] [Related]
48. Progressive intermittent claudication is associated with impaired fibrinolysis.
Killewich LA; Gardner AW; Macko RF; Hanna DJ; Goldberg AP; Cox DK; Flinn WR
J Vasc Surg; 1998 Apr; 27(4):645-50. PubMed ID: 9576077
[TBL] [Abstract][Full Text] [Related]
49. Relation of the prothrombotic state to increasing age (from the Framingham Offspring Study).
Tofler GH; Massaro J; Levy D; Mittleman M; Sutherland P; Lipinska I; Muller JE; D'Agostino RB
Am J Cardiol; 2005 Nov; 96(9):1280-3. PubMed ID: 16253598
[TBL] [Abstract][Full Text] [Related]
50. Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease.
Goicoechea M; de Vinuesa SG; Lahera V; Cachofeiro V; Gómez-Campderá F; Vega A; Abad S; Luño J
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S231-5. PubMed ID: 17130267
[TBL] [Abstract][Full Text] [Related]
51. Diabetes mellitus as a prothrombotic condition.
Grant PJ
J Intern Med; 2007 Aug; 262(2):157-72. PubMed ID: 17645584
[TBL] [Abstract][Full Text] [Related]
52. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men.
Targher G; Bertolini L; Rodella S; Lippi G; Franchini M; Zoppini G; Muggeo M; Day CP
Obesity (Silver Spring); 2008 Jun; 16(6):1394-9. PubMed ID: 18369343
[TBL] [Abstract][Full Text] [Related]
53. Fibrinolytic Dysregulation in Total Joint Arthroplasty Patients: Potential Clinical Implications.
Guler N; Burleson A; Syed D; Banos A; Hopkinson W; Hoppensteadt D; Rees H; Fareed J
Clin Appl Thromb Hemost; 2016 May; 22(4):372-6. PubMed ID: 26207021
[TBL] [Abstract][Full Text] [Related]
54. Hemostasis and fibrinolysis factors in first-degree relatives of patients with Type 2 diabetes without hypertension.
Trifiletti A; Lasco A; Scamardi R; Cincotta M; Gaudio A; Barbera N; Frisina N
Pathophysiol Haemost Thromb; 2002; 32(3):127-30. PubMed ID: 12372926
[TBL] [Abstract][Full Text] [Related]
55. The 4G/4G PAI-1 genotype is associated with elevated plasma PAI-1 levels regardless of variables of the metabolic syndrome and smoking status. A population-based study in Spanish population.
Martínez-Calatrava MJ; Martínez-Larrad MT; Zabena C; González-Sánchez JL; Fernández-Pérez C; Serrano-Ríos M
Diabetes Obes Metab; 2007 Jan; 9(1):134-5. PubMed ID: 17199731
[TBL] [Abstract][Full Text] [Related]
56. [Evolution of fibrinolysis status with D-dimer level and the rate of plasminogen activator inhibitor type-1/D-dimer in acute coronary syndrome patients complicated with impaired glucose tolerance].
Wu WD; Xu YH; Tan PY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Aug; 15(8):472-5. PubMed ID: 12919647
[TBL] [Abstract][Full Text] [Related]
57. Cognitive-behavioural stress management does not improve biological cardiovascular risk indicators in women with ischaemic heart disease: a randomized-controlled trial.
Claesson M; Birgander LS; Jansson JH; Lindahl B; Burell G; Asplund K; Mattsson C
J Intern Med; 2006 Oct; 260(4):320-31. PubMed ID: 16961669
[TBL] [Abstract][Full Text] [Related]
58. Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women.
Peverill RE; Teede HJ; Malan E; Kotsopoulos D; Smolich JJ; McGrath BP
Clin Sci (Lond); 2007 Nov; 113(9):383-91. PubMed ID: 17608627
[TBL] [Abstract][Full Text] [Related]
59. Family history of premature cardiovascular disease as a sole and independent risk factor for increased carotid intima-media thickness.
de Giorgis T; Giannini C; Scarinci A; D'Adamo E; Agostinelli S; Chiarelli F; Mohn A
J Hypertens; 2009 Apr; 27(4):822-8. PubMed ID: 19516181
[TBL] [Abstract][Full Text] [Related]
60. Hypofibrinolytic and atherogenic risk factors for stroke.
Glueck CJ; Rorick MH; Schmerler M; Anthony J; Feibel J; Bashir M; Glueck HI; Stroop D; Wang Y; Tracy TM
J Lab Clin Med; 1995 Mar; 125(3):319-25. PubMed ID: 7897298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
